Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $130.00K in the quarter ending March 31, 2025, a decrease of -12.16%. This brings the company's revenue in the last twelve months to $548.00K, up 15.61% year-over-year. In the year 2024, Ovid Therapeutics had annual revenue of $566.00K with 44.39% growth.

• Revenue (ttm): $548.00K
• Revenue Growth: +15.61%
• P/S Ratio: 39.25
• Revenue / Employee: $23,826
• Employees: 23
• Market Cap: 21.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	566.00K	174.00K	44.39%
Dec 31, 2023	392.00K	-1.11M	-73.91%
Dec 31, 2022	1.50M	-206.88M	-99.28%
Dec 31, 2021	208.38M	195.77M	1,551.57%
Dec 31, 2020	12.62M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.